What's New

Ruder Finn Asia’s Healthcare EVP relocates to Singapore

2011-05-26

Mai Tran, Executive Vice President, Health & Wellness, Ruder Finn Asia, has relocated from Beijing to Singapore to facilitate further developments of the company’s healthcare practice. In addition to extending Ruder Finn’s strong China portfolio and developing the local health offering in the key markets in the region, Mai will also work on the Asian components of global and regional programs, ensuring that global messages are suitably aligned and localized. With major healthcare companies making Singapore their regional headquarters, Ruder Finn Asia is looking at securing a similar leadership position in the region as it already has in China.

Mai’s move from Ruder Finn Paris to China in 2009 corresponded with China’s announcement of comprehensive healthcare reforms. In the past three years, Mai has focused on building up and strengthening the Health & Wellness offering in China, doubling the practice’s revenue and consolidating Ruder Finn as one of the leading healthcare PR practitioners in the country.

"I have known Mai for over 15 years, back to when she was running one of the most successful Healthcare consultancies in Shanghai. I look forward to having Mai in Singapore. Her experience in running the Ruder Finn French operations and European H&W campaigns in tandem with our US colleagues, as well as her long experience in the Asian market, will assist in expanding a seamless Health & Wellness offering across geographies," Ruder Finn Asia Chairman, Jean-Michel Dumont, said.

"When I moved to China, it was a wonderful challenge and opportunity for me especially when it became such an attractive country for the pharmaceutical industry," Mai Tran said. "My vision is to provide expertise, clear and informative insights to the healthcare companies in the whole of Asia. Only by experiencing the healthcare challenges such as aging, diabetes, obesity and all the other untreated diseases, will one understand the need for healthcare communication in the region. China is still very important but let’s not forget countries like Japan, India, and the rest of Asia."

RF has more than a decade of experience and expertise in healthcare communications in Asia and has established a strong reputation in the pharmaceutical industry. Clients include Novartis, Elsevier, Astellas Pharma, AstraZeneca, BD, Bristol-Myers Squib, Lundbeck, Mead Johnson, Merck Sharp & Dohme (MSD), Sanofi and Roche,

About Mai Tran

A trained Pharmacist with a business degree, Mai has extensive expertise in the Health sector with more than two decades of experience in communications, including eight years in China. Mai joined Ruder Finn France in 2001 as Client Director before becoming Managing Director in 2003, with a team of 15 dedicated healthcare consultants. Mai’s specialty is international public relations, with a focus on health and therapeutic areas including oncology, virology, obesity, endocrinology and cardiovascular. In the Oncology sector, Mai was part of the global communications team for Novartis Oncology’s Glivec and Femara while in the cardiovascular arena, she worked with Sanofi-Aventis and Bristol-Myers Squibb on Plavix. She also worked on the launch of Novartis hypertension treatments and supported communications for Roche and the diabetes BMS/AZ franchise. Mai has also worked with learned societies, among them, European Society of Cardiology and the European Association for the Study of the Liver. She participated in the launch of two AIDS drugs for Tibotec and Janssen-Cilag.

From 1995 to 2000, Mai worked in Beijing and Shanghai as Managing Director of the Chinese branch of PR International, .where she built the agency from the ground up, creating at that time the biggest healthcare team of consultants in China and negotiating the first PR joint venture with the Ministry of Health in China. Mai began her career as a journalist at one of the most influential French medical daily newspapers.

******

Ruder Finn, Inc. is one of the largest independent integrated communication firms in the world, with offices in the United States and Europe, as well as in Beijing, Shanghai, Guangzhou, Hong Kong, Singapore, Mumbai and New Delhi in Asia. Through these offices and our affiliates worldwide, the agency serves the global and local communication needs of over 250 corporations, governments and non-profit organizations. For more than 60 years, the Ruder Finn name has been synonymous with excellence in communications. Ruder Finn’s global strategic focus is on four operational pillars which constitute the core of our growth – Health & Wellness, Corporate & Public Trust, Global Connectivity and Life+Style.

In Asia, Health & Wellness includes GE Healthcare, Mead Johnson, Novartis, Pfizer, Roche, Sanofi and Weight Watchers. Corporate & Public Trust includes L’Oreal, Founder Group, Michelin, Boeing, Bosch, Volkswagen, Citic Bank,Singapore EDB, Visa, LANXESS, Amazon, Omron and Carlsberg.. Life+Style includes luxury brands like Cartier from the Richemont Group, Givenchy from the LVMH Group, as well as Hermes, Bang & Olufsen, Lamborghini, Lexus, Tod’s Group, Breitling and the Jumeirah Group. Global Connectivity includes DHL, Emirates, Hawker Beechcraft, IEEE and Contact Singapore. Those four pillars are supported by award-winning divisions such as RFI, focusing on Interactive, Social Media and ePR and INSIGHT which focuses on research and trends, producing the China Luxury Forecast and the CSR Index with Tsinghua University. For more information on Ruder Finn, please visit www.ruderfinn.com orwww.ruderfinnasia.com, or Chinese website http://cn.ruderfinnasia.com